Clinical Scorecard: Persistence of SARS-CoV-2 in Gastric and Gallbladder Tissues of Patients with a History of COVID-19 Undergoing Bariatric Surgery

At a Glance

Key Highlights

• SARS-CoV-2 viral antigens can persist in gastric and gallbladder tissues despite negative PCR tests at surgery time.
• Potential risk of viral aerosolization during laparoscopic bariatric surgery due to electrocautery and energy devices.
• Study conducted with 80 patients, using immunohistochemical staining to detect viral nucleocapsid proteins in tissue specimens.

Guideline-Based Recommendations

Diagnosis

• Consider immunohistochemical detection of SARS-CoV-2 nucleocapsid proteins in gastrointestinal tissues for patients with prior COVID-19.
• Use negative PCR test results preoperatively but be aware of possible tissue viral persistence.

Management

• Maintain strict infection control measures during laparoscopic bariatric surgeries to mitigate aerosolization risks.
• Evaluate patient history of COVID-19 and gastrointestinal symptoms prior to bariatric procedures.

Monitoring & Follow-up

• Monitor postoperative outcomes using Clavien-Dindo classification and Global Outcome Benchmark values for laparoscopic sleeve gastrectomy.

Risks

• Potential exposure of operating room staff to aerosolized SARS-CoV-2 during laparoscopic procedures.
• Uncertainty regarding infectivity of persistent viral antigens in gastrointestinal tissues.

Patient & Prescribing Data

Patients with prior COVID-19 infection undergoing bariatric surgery with negative PCR at surgery time

No direct treatment changes indicated; awareness of viral persistence may influence surgical precautions and postoperative monitoring.

Clinical Best Practices

• Perform thorough preoperative assessment including COVID-19 history and gastrointestinal symptoms.
• Use immunohistochemistry for detecting SARS-CoV-2 in tissue specimens when investigating viral persistence.
• Apply enhanced protective measures for surgical teams during laparoscopic procedures to reduce aerosol exposure.
• Follow standardized postoperative outcome assessments to monitor surgical safety and complications.

References

• Clavien-Dindo classification for surgical outcomes
• Global Outcome Benchmark values for LSG
• Elecsys Anti-SARS-CoV-2 assay (Roche Diagnostics)